Clinical Trials Browser

Unknown × Hematologic Neoplasms × Clear all

NCT05735704 2025-03-26

SANGUINE

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT04298892 2024-07-01

INTHEMA

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

NCT05787964 2024-05-09

SYS01

Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

NCT05583734 2024-04-23

A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy

Phase NA Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT06339541 2024-04-01

ACC Platform

Other hematologic neoplasm

Hematologic Neoplasms

NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Phase NA Unknown

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT06224452 2024-03-05

Is Ibrutinib-related Atrial Fibrillation Dose Dependent

18,000 enrolled

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms

NCT06279585 2024-02-28

Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD

Phase NA Unknown

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Motor Activity, Hematologic Neoplasms

NCT06066255 2024-02-20

CASPER

Phase 2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT06258629 2024-02-14

Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality

Other hematologic neoplasm

Hematologic Neoplasms

NCT06238336 2024-02-02

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Phase 2/3 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT04776005 2024-01-03

COVIDVAC OH

Other hematologic neoplasm

COVID-19, Neoplasms, Second Primary, Hematologic Neoplasms

NCT03236129 2023-12-18

DLI-Boost

Phase 3 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT05692713 2023-12-08

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Hematologic Neoplasms

NCT04372524 2023-12-05

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Hematologic Neoplasms

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Phase NA Unknown

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT06134297 2023-11-18

Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation

Phase NA Unknown

Other hematologic neoplasm

Fatigue, Hematologic Neoplasms

NCT06130709 2023-11-14

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms

NCT05716919 2023-10-23

Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule

Phase 1 Unknown

Other hematologic neoplasm

Fibrosis, Hematologic Neoplasms

NCT05510089 2023-10-10

Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

Phase NA Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05222282 2023-09-28

Sexual Health in Patients With Hematologic Malignancies

Phase NA Unknown

OtherOther hematologic neoplasm

Sexual Dysfunction, Physiological, Signs and Symptoms, Hematologic Neoplasms, Sexuality

NCT06041815 2023-09-18

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Other hematologic neoplasm

Hematologic Neoplasms

NCT05629260 2023-09-11

The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

Other hematologic neoplasm

Hematologic Neoplasms

NCT05784870 2023-08-25

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Phase 3 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05758207 2023-08-15

Oral Complications in Hematological Malignancies

Other hematologic neoplasm

Hematologic Neoplasms

NCT05690425 2023-07-24

A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Phase 2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT03806764 2023-06-01

CReSCT

Phase NA Unknown

Other hematologic neoplasm

Cytomegalovirus Infections, Virus Diseases, Hematologic Neoplasms

NCT05808296 2023-04-11

The Effect of Lavender Oil on Fatigue and Sleep Quality

Phase NA Unknown

Other hematologic neoplasm

Fatigue, Patient Participation, Sleep Wake Disorders, Hematologic Neoplasms

NCT05759975 2023-03-08

Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT

Phase NA Unknown

Other hematologic neoplasm

Stomatitis, Xerostomia, Hematologic Neoplasms

NCT04809181 2023-02-21

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT05709522 2023-02-02

PBT

CNSOther hematologic neoplasm

Brain Neoplasms, Depression, Hematologic Neoplasms

NCT04280133 2023-01-26

CAR T-CELL Therapy Educational Video Trial

Phase NA Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05672420 2023-01-05

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Phase 1/2 Unknown

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Hemorrhage, Infections, Leukemia, Lymphoma, Multiple Myeloma, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT05626764 2022-11-25

QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT05610202 2022-11-09

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05609227 2022-11-08

Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation

Phase NA Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05602051 2022-11-01

Mindfulness-based Virtual Reality Intervention

Phase NA Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05413356 2022-10-19

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Phase 2 Unknown

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT04352556 2022-09-23

COVID19-hematological Malignancies: the Italian Hematology Alliance

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT05489276 2022-08-05

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05355675 2022-08-02

The Association of Microbiota Composition With cGVHD After Allo-HSCT

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT03373656 2022-07-26

Vaccination for Children of H&O and Their Parents

Phase NA Unknown

Other hematologic neoplasm

Immunologic Deficiency Syndromes, Hematologic Neoplasms

NCT05455866 2022-07-13

KTcCHO

Other hematologic neoplasm

Hematologic Neoplasms, Upper Extremity Deep Vein Thrombosis

NCT05212584 2022-07-06

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05445765 2022-07-06

Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05443854 2022-07-05

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Phase 3 Unknown

Other hematologic neoplasm

Neoplasms, Shock, Septic, Sepsis, Hematologic Neoplasms

NCT04632316 2022-06-21

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Phase 3 Unknown

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms